February was a busy month for C4IP! Here’s a roundup of what our Coalition accomplished over the past month. February Highlights: Protecting the Bayh-Dole Act February 6 concluded NIST’s public comment period for the newly proposed “march-in” framework, which would twist the Bayh-Dole Act into a mechanism for government price control. If implemented, such government
Former USPTO Director and C4IP Co-Chair David Kappos published an opinion piece this week in the Brussels Times advocating against the European Parliament’s proposal to micromanage standard-essential patent (SEP) licensing, which would represent a massive blow to European tech innovators if adopted. Kappos explains how the European Parliament’s proposal, which would task bureaucrats with managing
Claim: During a January 23 Senate Judiciary Subcommittee on Intellectual Property hearing, Richard Blaylock — on behalf of Invitae Corporation — claimed that “PERA as introduced would stifle innovation and harm patient care in the fields of diagnostic genetic testing and precision medicine.” Correction: The Patent Eligibility Restoration Act (PERA) is an essential reform to
C4IP is recognizing John Kellogg, whose invention of the first breakfast cereal transformed American nutrition. John Harvey Kellogg was born in Michigan in February 1852. Kellogg learned early on to value healthy living, which ultimately led him to pursue a career in medicine. He studied at the University of Michigan Medical School and later at Bellevue Hospital Medical College, where
Happy New Year! C4IP’s 2024 has been off to a busy start. Here’s a roundup of what our Coalition has accomplished so far this year. On January 31, C4IP Co-Chair Andrei Iancu and former NSCAI Director of Research and Analysis Rama Elluru published an opinion essay in Reuters centered on the intersection of artificial intelligence
Innovation requires IP. Without a strong patent system, innovation does not happen at scale. Virtually every invention of impact is patented, as exemplified by these historical examples from the month of January: 1967: On January 3, Harry Thomason received a patent for technology to heat and cool a building using solar energy. Thomason’s invention is
Claim: On December 7, the Biden administration proposed a policy framework claiming a newfound authority, under the 43-year-old Bayh-Dole Act, to rescind patent licenses on drugs, energy, climate change, and all other inventions that benefit from federal research funding based on the price of the resulting product. The administration asserts that this framework is an
Yesterday, the C4IP Board published an opinion piece in Euractiv highlighting how the European Commission’s recent proposal for standard-essential patents (SEPs) has empowered China to unilaterally set its own licensing terms, jeopardizing a longstanding model of international cooperation and threatening Europe’s own leadership in wireless technology. In the piece, the board explains how SEPs —
C4IP is highlighting the accomplishments of Ashok Gadgil from the University of California, Berkeley. His groundbreaking invention, utilizing ultraviolet light to purify water, was brought to market pursuant to the Bayh-Dole Act and has since saved millions of lives across the globe. Ashok Gadgil was born in Mumbai, India, in 1950. He attended the University
Over the weekend, C4IP Co-Chairs and former USPTO Directors David Kappos and Andrei Iancu published an opinion piece in The Hill detailing how the Biden administration’s new proposal for march-in rights under the Bayh-Dole Act would decimate innovation across numerous crucial technology sectors. The administration’s unprecedented proposal, announced in December, would allow government bureaucrats to
Merrill Matthews, a resident scholar with the Institute for Policy Innovation, recently published an opinion piece in RealClearHealth calling attention to the numerous attacks on intellectual property that are exacerbating ongoing shortages of prescription medicines. More than 300 drugs are currently in shortage, including 15 cancer drugs, due to falling profit margins in the drug
The Bayh-Dole Act revolutionized U.S. innovation by decentralizing the licensing process for federally funded research. By giving universities and other nonprofits the ability to license their researchers’ discoveries to the private sector, the Bayh-Dole Act incentivized them to turn their cutting-edge research into tangible products. The law’s impact has proven substantial, contributing nearly $2 trillion
